
What We’re Reading: US Authorizes Pfizer Oral COVID-19 Drug; Omicron May Be Milder; More Cities Require Vaccinations
The United States has authorized Pfizer’s oral COVID-19 treatment for at-home use; study results show that the Omicron variant may have a lower risk of hospitalization; and Chicago and Boston announce proof of vaccination requirements for indoor settings.
US Authorizes Pfizer’s Oral COVID-19 Treatment
The United States authorized Pfizer’s antiviral COVID-19 pill (Paxlovid) for people aged 12 years or older who are at risk of severe illness, according to
Omicron May Carry Lower Hospitalization Risk
According to the
Chicago, Boston to Require Proof of Vaccination for Indoor Spaces
Starting in January, Boston and Chicago will install mandates that will require people to produce proof of vaccination against COVID-19 in order to enter indoor spaces, including gyms, restaurants, and entertainment venues. According to a report by
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.